Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Beauty experts unite: new guidelines for safer skin treatments in MENA

NCT ID NCT07261748

Knowledge-focused Sponsor: Venus Research Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study brings together 15 dermatologists and aesthetic doctors from the Middle East and North Africa to create expert guidelines for using poly-L-lactic acid (PLLA) injections, a collagen-boosting treatment for skin aging. Most current guidelines are based on lighter skin types, so this project focuses on the unique needs of Fitzpatrick III-VI skin types common in the region. No patients are involved—only expert opinions collected through online surveys.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Poly-L-lactic acid (PLLA) biostimulator
What this could lead to
If successful, this could lead to region-specific guidelines that help doctors use PLLA more safely and effectively for people with darker skin types in the Middle East and North Africa.
What could go wrong
This is a small expert-opinion study with no patients or treatments involved. The final guidelines are based on consensus, not direct evidence, and may not reflect real-world outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 15 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

A purposively selected group of dermatology and aesthetic medicine experts from Egypt and the broader MENA region. Participants are clinicians with significant experience using poly-L-lactic acid (PLLA) biostimulators and are invited to contribute to a structured Modified Delphi process to develop regional consensus recommendations.

Ages

25 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Board-certified dermatologist or plastic surgeon OR physician practicing aesthetic medicine. * Minimum of 5 years of clinical experience OR ≥50 documented PLLA cases. * Practicing within Egypt or the Middle East and North Africa (MENA) region. * Willingness to participate in Delphi rounds and provide expert ratings. * Ability to read and respond to surveys in English. Exclusion Criteria: * Inability or unwillingness to complete Delphi rounds. * Lack of clinical experience with PLLA. * Industry representatives without direct clinical practice.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aesthetic procedures are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aesthetic procedures Cosmetic techniques Rejuvenation Skin aging

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Venus Research Center

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.